Background/Aims: A recent study has shown that 1,25-dihydroxyvitamin D3 (1,25-D3), the active form of vitamin D, can ameliorate renal dysfunction. In this study, we aimed to determine the role of 1,25-D3 in angiotensin (Ang II)-induced renal injury and investigate the underlying mechanisms involved. Methods: C57BL/6J mice were treated with Ang II and/or 1,25-D3 (or saline as the control) for 2 weeks. Renal injury was evaluated using transmission electron microscopy and periodic acid-Schiff reagent and Masson's trichrome staining. The pro-fibrotic and pro-inflammatory factors were assessed using real-time PCR. The renal apoptotic pathway was evaluated with TUNEL staining and western blot. Mitochondrial dysfunction (MtD) was determined using real-time PCR and electron microscopy. The activation of autophagy was detected using western blot. Results: In the Ang II-infused mice, expanded mesangial regions, tubulointerstitial fibrosis, and foot process fusion were observed; the levels of the pro-fibrotic and pro-inflammatory cytokines and MtD were also increased when compared with the control group. However, we found that administration of 1,25-D3 significantly improved renal function and MtD and reduced the pro-fibrotic and pro-inflammatory cytokine levels. Furthermore, 1,25-D3 significantly inhibited Ang II-induced autophagy dysfunction (determined by inhibition of Beclin-1 activation and reduction of the LC3-II/LC3-I ratio). Conclusion: Our findings suggest that 1,25-D3 may attenuate Ang II-induced renal injury by improving MtD and modulating autophagy. 1,25-D3 may be a new therapeutic for the treatment of CKD.
Introduction
End-stage renal disease (ESRD) is the last phase of chronic kidney disease (CKD). The prevalence of ESRD is increasing worldwide, which is a problem for the healthcare system of different countries [1] . The renin-angiotensin system (RAS) is a cascade of essential mediators for a wide variety of physiological and pathophysiological events in kidney disease. Overactivation of the angiotensin II (Ang II) type 1 receptor (AT1R) axis, the classical regulator of RAS, has been shown to play a key role in the development of renal disease. Ang II is a peptide hormone with a dual role in pathophysiological (including pro-inflammatory and pro-fibrotic) and physiological (including blood pressure control and sodium homeostasis) conditions [2] . Blockade of Ang II is widely used to improve the progression of renal disease [3] . Benigni showed that blocking Ang II synthesis/activity inhibited glomerular nephrin in rats with severe nephrosis [4] . In addition, Suzuki et al. found that the Ang II subtype 1 (AT1) receptor regulated a reduction in the functional molecules of podocytes [5] .
The mitochondria are intracellular organelles with important roles in maintaining cellular energy metabolism, and they are a major source of reactive oxygen species (ROS) [6] . Mitochondrial dysfunction (MtD) can cause inflammation, oxidative damage, and subsequent cell damage. We had previously determined that the mitochondrial complex I inhibitor rotenone attenuated aldosterone-infused rats by inhibiting oxidative stress and MtD. The mitochondria could be the first injury target of mitochondrial-derived ROS, forming a positive pathogenic crosstalk between mitochondrial-derived ROS and MtD [7, 8] . Ang II has been shown to play an important role in mitochondrial homeostasis. Wen et al. have demonstrated that Ang II induces NLRP3 inflammasome activation and kidney damage via mitochondrial dysfunction [9] . Because MtD plays a key role in the development of renal injury, treatment strategies that specifically target the mitochondria may prove to be a therapeutically beneficial approach for ESRD.
Macroautophagy, generally referred to as autophagy, is a conserved, genetically regulated, and ubiquitous pathway that allows cells to remove defective organelles, recycle cytoplasmic components, and maintain cellular functions [10] . Generally, autophagy occurs at a basal rate in most cells and helps in maintaining cellular homeostasis. However, autophagic activity has been observed to be upregulated under physiological stress, such as starvation, oxidative stress, pathogen infection, and endoplasmic reticulum stress [11] . Previous studies have shown that dysregulated autophagy is involved in disorders characterized by fibrosis in various tissues, including those of the lung and liver [12, 13] . Recently, a potential mechanistic link between RAS overactivation and autophagic induction was reported; Porrello et al. demonstrated that autophagy is induced by Ang II via AT1R in cardiomyocytes, leading to the progression of heart failure [14] . In addition, Yadav showed that Ang II promoted podocyte autophagy through the generation of ROS, which was inhibited by antioxidants [15] .
Vitamin D is a fat-soluble steroid hormone that regulates calcium-phosphorus homeostasis. 1,25-Dihydroxyvitamin D3 (hereafter, 1,25-D3), the active form of vitamin D, is a primary mediator of calcium homeostasis that affects bone metabolism [16] . Vitamin D receptor (VDR)-dependent vitamin D could regulate various processes, such as inflammation, apoptosis, immunomodulation, and autophagy [17] . 1,25-D3 has been shown to function as a key negative regulator of RAS. Vitamin D analogs could ameliorate renal injury in various experimental models of CKD [18, 19] ; however, its molecular mechanism is unclear. In the present study, we investigated whether 1,25-D3 attenuates Ang II-induced renal injury by improving MtD and modulating autophagy. 
Materials and Methods

Reagents and antibodies
Ang II, 1,25-D3, and Anti-LC3 antibody were purchased from Sigma-Aldrich (St. Louis, MO). Rabbit polyclonal anti-caspase-3 and Beclin-1 were purchased from Cell Signaling Technology (Beverly, MA).
Animal preparation
The experiments were performed according to the guide for laboratory animals of Shanghai Jiaotong University. Eight-week-old male C57BL/6 mice that weighed 22-25 g were obtained from the Shanghai SLAC Lab. All the mice were divided into 3 groups and treated for 2 weeks as follows: Sham group (0.5% ethanol subcutaneously, saline vehicle i.p., n = 6); Ang II group (Ang II 500 ng/kg/min subcutaneously, saline vehicle i.p., n = 6) [20] ; and Ang II + 1,25-D3 group (Ang II 500 ng/kg/min subcutaneously, 1,25-D3, 120 ng/kg/day, i.p., n = 6) [21] . An osmotic mini-pump was implanted subcutaneously to infuse either ethanol or Ang II. At the end of the experiment, the mice were anesthetized and 4-µm-thick kidney sections were obtained, fixed in 10% formalin, and embedded in paraffin.
Histological and IHC studies
The kidney sections were stained with periodic acid-Schiff (PAS) reagent or Masson's trichrome by using a standard procedure described in a previous study. After PAS staining, severity of glomerular injury in experimental mice was evaluated accordance with the following semi-quantitative grades: grade 0, normal; grade 1, segmental lesion <25%; grade 2, 25%-50%; grade 3, 50%-75%; grade 4, 75%-100%. At least 20 glomeruli were analyzed in each group. As for tubulointerstitial fibrosis index, the areas of interstitial fibrosis were evaluated in 10 random 400× magnification fields obtained from Masson trichrome staining [22] . The sections were also stained with F4/80 (1:1000) antibody and the immunohistochemistry was quantified as described in our previous study [22] . In brief, the immunohistochemistry of F4/80 was performed on paraffin-embedded renal tissue and imaged after incubated with secondary antibodies. Positive cells (brown pixels) were calculated from 10 high power fields per group to indicate cell infiltration in kidney.
Transmission electron microscopy
To assess podocyte foot processes and mitochondrial ultrastructure morphology, the samples were cut into ultrathin sections (60-70 nm) with an ultramicrotome and stained with uranyl acetate and lead citrate. All these experiments were performed as described previously [7] .
Real-time PCR
Total RNA was isolated from renal tissue by using TRIzol reagent (Invitrogen), reverse-transcribed to cDNA, and subjected to PCR amplification, according to our previous study. Real-time PCR was performed using the ABI 7500 real-time PCR system (Applied Biosystems). The following SYBR green real-time PCR primers were used: CTGF, forward 5′-GAGGAAAACATTAAGAAGGGCAAA-3′; reverse 5′-CGGCACAGGTCTTGATGA-3′; TGF-β, forward 5′-GAGGTGACCTGGGCACCAT-3′; reverse 5′-GGCCATGAGGAGCAGGAATCCTGCTGG-3′; collagen IV, forward 5′-ATCATTGCCATCTGGAGACACCT-3′; reverse 5′-TACCATTTCTTCAACCTGGGAGC-3′; IL-1β, forward 5′-AGCCTTTGTCCTCTGCCAAGT-3′; reverse 5′-CCAGAATGTGCCACGGTTTT-3′; ATP synthase, forward 5ʹ-TCCATCAAAAACATCCAGAAAA-3ʹ; reverse 5ʹ-GAGGAGTGAATAGCACCACAAA-3ʹ; 18S, forward 5ʹ-TTCGGAACTGAGGCCATGATT-3ʹ; reverse 5ʹ-TTTCGCTCTGGTCCGTCTTG-3ʹ; and mtDNA, forward 5ʹ-TTTTATCTGCATCTGAGTTTAATCCTGT-3ʹ; reverse 5ʹ-CCACTTCATCTTACCATTTATTATCGC-3ʹ [7, 23] .
Terminal deoxyribonucleotide transferase-mediated dUTP nick-end labeling (TUNEL) assay
Apoptosis in renal tissue sections was determined using the TUNEL assay, according to a previous study [8] . Briefly, the deparaffinized sections were washed with PBS and incubated with 50 µl of the TUNEL reaction mixture for 60 min at 37°C in the dark. For quantification, 10 fields were randomly selected, and 
Western blot
Proteins from the kidney tissue were homogenized or lysed using standard protocols, followed by 10 min of boiling and centrifugation to obtain the lysates. The protein concentrations were determined using the BCA protein assay kit. Equal quantities of protein (30 μg) were separated using SDS-PAGE and then transferred onto nitrocellulose membranes and incubated with primary antibodies against caspase-3, Beclin-1, and LC3. The blots were washed with TBST and incubated with secondary antibodies for 2 h, and the protein bands were detected using an enhanced chemiluminescent system.
Statistical analysis
All data were presented as means ± standard error of the mean (SEM). Statistical analysis was performed using Student's t-test or one-way ANOVA, followed by post-hoc tests. A P value <0.05 was considered statistically significant.
Results
Effects of 1, 25-D3 on renal function in the Ang II-infused mice
Renal damage was determined using PAS reagent, Masson's trichrome staining, and transmission electron microscopy. When compared with the sham group, the Ang II-infused mice demonstrated significantly expanded mesangial regions and glomerulosclerosis ( Fig.  1A and 2B ). However, treatment with 1,25-D3 markedly decreased the glomerular injury 
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Cellular Physiology and Biochemistry score. Similarly, significant tubulointerstitial fibrosis was induced in the Ang II-infused mice, and when compared with the sham group, the Ang II/1,25-D3 group showed a significantly reduced tubulointerstitial fibrosis index (Fig. 1B and 2C ). Using transmission electron microscopy, the glomerular filtration membrane was damaged in the Ang II-infused mice, with foot process fusion. The treatment with 1,25-D3 significantly improved the glomerular structure damage (Fig. 2A) .
Effects of 1, 25-D3 on renal fibrosis and inflammation in the Ang II-infused mice
The pro-fibrotic and pro-inflammatory factors were assessed using real-time PCR (Fig.  3) . When compared with the sham group, the Ang II-infused mice showed significantly increased TGF-β (5.35-fold) and collagen IV (3.92-fold) levels. However, treatment with 1,25-D3 significantly decreased these pro-fibrotic factors. In addition, the pro-inflammatory factors IL-1β (3.51-fold) and CTGF (2.45-fold) were markedly increased in the Ang II-infused mice. These pro-inflammatory factors were significantly reduced in the Ang II/1,25-D3 group. Similarly, consistent with these changes above, Ang II-infused mice demonstrated severely aggravated immune cell infiltration of F4/80-positive macrophages at day 14 (Fig. 4) . Quantification analysis showed that treatment with 1,25-D3 markedly reduced the cellular infiltration, compared with Ang II-infused mice. 
Effects of 1, 25-D3 on Ang II-induced apoptosis and renal injury
Apoptosis is a key detrimental outcome of progressive kidney disease, and apoptotic cells were detected in the Ang II-infused mice. TUNEL staining demonstrated significantly more apoptotic cells in the Ang II-induced mice than in the sham mice; the treatment with 1,25-D3 significantly reduced Ang II-induced apoptosis ( Fig. 5A and 5B). This was confirmed by cleaved-caspase 3 expression; cleaved-caspase 3 levels (2.67-fold) were increased significantly in the Ang II-induced mice, and this increase was significantly inhibited in the Ang II/1,25-D3 group (Fig. 5C) .
Effects of 1, 25-D3 on Ang II-induced MtD
To detect the effects of 1,25-D3 on MtD, we evaluated mitochondrial morphology, mtDNA and ATP synthase levels. Our results showed that the mitochondria in the Ang II-infused mice were swollen with disorganized and fragmented cristae (Fig. 6A ). The treatment with 1,25-D3 reversed the abnormal mitochondrial morphology. Moreover, the mtDNA and ATP synthase were reduced in the Ang II-infused mice when compared with the sham group; and these decreased levels were attenuated by treatment with 1,25-D3 (Fig. 6B and 6C) .
Effects of 1, 25-D3 on Ang II-induced autophagy
In addition to apoptosis, autophagy has been suggested to be involved in Ang-IIinduced renal damage [15] . To confirm this, Beclin-1, considered as an important marker of autophagy induction, was detected. The activation of Beclin-1 (6.45-fold) was increased in the Ang-II-infused mice when compared with the sham group, and treatment with 1,25-D3 significantly inhibited Beclin-1 expression (Fig. 7) . To further confirm the effects of 1,25-D3 
Discussion
In the present study, we observed that 1,25-D3 has an anti-fibrotic and protective role in Ang II-induced renal injury. We also found that 1,25-D3 prevented Ang II-induced renal injury via multiple mechanisms. 1,25-D3 improved renal function by inhibiting the inflammatory process, ameliorating renal tubular cell apoptosis and injury, attenuating MtD, and inhibiting autophagy. These results suggest that 1,25-D3 is a therapeutic candidate with multiple properties.
In this study, renal fibrosis was significantly attenuated by the 1,25-D3 treatment. The extent of renal fibrosis was strongly correlated with renal function deterioration, suggesting the important anti-fibrotic role of 1,25-D3 in Ang II-infused renal injury. 1,25-D3 attenuated renal fibrosis by inhibiting ECM component synthesis and pro-fibrotic factors. TGF-β and collagen type IV were the main targets of Ang II in renal fibrosis. Blocking TGF-β is effective for improving renal fibrosis [24] . Recently, connective tissue growth factor (CTGF) has also emerged as a new anti-fibrotic target because it is more than a downstream mediator of TGF-β [25] . In this study, TGF-β, CTGF and collagen IV levels were significantly increased in the Ang II-infused mice; treatment with 1,25-D3 markedly inhibited these pro-fibrotic mediators, suggesting the direct effect of 1,25-D3 on TGF-β/CTGF/collagen IV-mediated renal fibrosis.
Renal inflammation is considered as an initial protective response to various types of injuries. However, prolonged and excessive inflammation could lead to progressive kidney damage [26] . Ang II stimulated various pro-inflammation response, including nuclear factor kappa B activation and macrophage/lymphocyte proliferation. Recent study also showed that Ang II directly induced inflammation via Nlrp3 inflammasome activation and triggered maturation of IL-1β [9] . In present study, In the Ang II-induced group, levels of the proinflammatory factors IL-1β was significantly increased. Similarly, consistent with these changes, Ang II-infused mice demonstrated severely aggravated immune cell infiltration of F4/80-positive macrophages at day 1 Compared with Ang II-infused mice, treatment with 1,25-D3 markedly reduced the cellular infiltration and IL-1β levels. These results may indicate that 1,25-D3 ameliorates renal fibrosis by preventing the inflammatory response. Tubular cell apoptosis has also been implicated in various types of kidney disease. Apoptosis promotes the loss of renal epithelial cells, which is observed in acute kidney disease and CKD. The apoptotic pathways activated in glomerular and tubular epithelial cells induce death receptor activation, mitochondrial and endoplasmic reticulum stress, and caspase cascade activation [27] . Our data showed that the TUNEL-positive cells and cleaved-caspase-3 levels were significantly increased in the Ang II-infused group. However, treatment with 1,25-D3 markedly attenuated renal cell apoptosis, indicating 1,25-D3 protects renal function against apoptosis in Ang II-infused kidney damage.
Previous studies have suggested that MtD is mainly observed in acute kidney injury and CKD [28, 29] . Our previous study demonstrated that NLRP3 deficiency may attenuate renal fibrosis by improving MtD in a mouse unilateral ureteral obstruction model for CKD [22] . The characteristic features of MtD include abnormal mitochondrial morphology and reduction in mtDNA and ATP production. In this study, MtD was observed in the Ang IIinfused mice, which had decreased mtDNA copy number and ATP synthase levels. The renal epithelial tubular cells also showed a markedly abnormal mitochondrial morphology. The 1,25-D3 treatment significantly ameliorated Ang II-induced MtD in the mice, which may be a potential mechanism by which 1,25-D3 inhibits renal fibrosis.
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Autophagy is a process in which cytoplasmic materials, including organelles, reach the lysosomes for degradation. Although autophagic activity is very important for homeostasis in cells, excessive autophagy could lead to type II programmed cell death [30] . Autophagy is involved in various types of disease, including Ang II-induced kidney injury 15. In this study, we observed that Ang II dramatically induced autophagosome formation by upregulation of Beclin-1. Furthermore, increased conversion of LC3-I to phosphatidylethanolamineconjugated LC3-II was observed in the Ang II-infused mice, suggesting enhanced autophagy. We further demonstrated that 1,25-D3 inhibited Ang II-induced autophagy dysfunction by decreased Beclin-1 expression and LC3-II/LC3-I ratio. Our results were consistent with Yao and co-workers research [31] . In addition, according to recent research, 1,25-Dihydroxyvitamin D3 was a negative endocrine regulator of the renin-angiotensin system, and vitamin D receptor attenuated renal fibrosis by suppressing the renin-angiotensin system [18, 32] . A large number of research evidence also showed that Ang II could induce autophagy activation directly. According to these results above, we suggested that 1,25-Dihydroxyvitamin D3 may inhibit Ang II-induced autophagy by partly inhibitory action of Ang II in present study.
1,25-D3, the most active vitamin D3 metabolite, is generated by its initial hydroxylation in the liver and kidney. 1,25-D3 binds to VDR and develops its biological activity [33] . A previous study has suggested the potential anti-inflammatory and anti-fibrotic activities of 1,25-D3 in CKD [34] . Chambers et al. have shown that vitamin D and VDRAs may exert immunomodulatory actions by direct regulation of macrophages, dendritic cells, and T cells [35] . In the present study, we found that 1,25-D3 attenuated Ang II-infused proinflammatory cytokines and renal fibrosis. We also found that 1,25-D3 inhibited Ang II-induced autophagy dysfunction and MtD and identified a novel mechanism of action for 1,25-D3.
Conclusion
we showed that 1,25-D3 attenuates Ang II-induced renal injury by improving inflammation, MtD, and autophagy dysfunction. Our data provide an experimental basis for further evaluation of the mechanisms underlying the renal protective role of 1,25-D3.
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